Showing results (41-50 of 437) with videos related to

Sort By:
Pageof 44
Rheumatology (Oxford, England)|October 10, 2017
Points to consider for designing trials in systemic sclerosis patients with arthritic involvementPhilip Clements, Yannick Allanore, Daniel E Furst, et al.
Seminars in Arthritis and Rheumatism|August 4, 2006
Tumor necrosis factor antagonists: different kinetics and/or mechanisms of action may explain differences in the risk for developing granulomatous infectionDaniel E Furst, Robert Wallis, Michael Broder, et al.
Rheumatic Diseases Clinics of North America|July 5, 2003
Update on disease-modifying antirheumatic drugs in the treatment of systemic sclerosisAntony T H Lin, Philip J Clements, Daniel E Furst
Arthritis and Rheumatism|July 28, 2006
Gout and the risk of acute myocardial infarctionEswar Krishnan, Joshua F Baker, Daniel E Furst, et al.
The Journal of Rheumatology|December 19, 2007
Does incorporation of aids and devices make a difference in the score of the health assessment questionnaire-disability index? Analysis from a scleroderma clinical trialDinesh Khanna, Philip J Clements, Arnold E Postlethwaite, et al.
Seminars in Arthritis and Rheumatism|November 2, 2013
Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis SurveyMarie Hudson, Murray Baron, Solène Tatibouet, et al.
Statistical Methods in Medical Research|March 7, 2007
Assessing disease progression using a composite endpointWeng Kee Wong, Daniel E Furst, Philip J Clements, et al.
Arthritis Research & Therapy|September 15, 2007
Clinical trials in systemic sclerosis: lessons learned and outcomesMarco Matucci-Cerinic, Virginia D Steen, Daniel E Furst, et al.
International Journal of Rheumatology|December 12, 2017
Review of Routine Laboratory Monitoring for Patients with Rheumatoid Arthritis Receiving Biologic or Nonbiologic DMARDsWilliam F C Rigby, Kathy Lampl, Jason M Low, et al.
Arthritis Care & Research|March 1, 2021
Discrepancy Between Multibiomarker Disease Activity and Clinical Disease Activity Scores in Patients With Persistently Active Rheumatoid ArthritisRoy Fleischmann, Jingyu Liu, Julie Zhu, et al.
Pageof 44